Matthew Kelly, PhD
As a postdoctoral trainee in the lab of Dr. Dai Yamanouchi, I am investigating the molecular mechanisms underlying aneurysm formation, with a focus on the role of macrophage activation in disease development. I received my bachelor’s, master’s, and doctoral degrees from the University of Wisconsin-Madison. During my undergraduate studies, I was fortunate to obtain research experience while working in the lab of Dr. Miroslav Malkovsky. This invaluable experience sparked my interest in immunology, particularly how the immune system contributes to both disease protection and progression. I completed my graduate work in Dr. Malkovsky’s lab investigating the construction and application of DNA and cellular vaccines against melanoma and prostate cancer. In addition to research, I’ve enjoyed teaching basic and intermediate level science courses as a teaching assistant and instructor at the University of Wisconsin, Madison College, and Truman College in Chicago.
Jennifer Philip, MD
As a postdoctoral fellow in Dr. Naomi Chesler’s group, I pursue exciting research in the area of vascular tissue biomechanics with a specific focus on pulmonary hypertension. I received my undergraduate degree in chemical engineering from Washington University in 2009. Following which attended the University of Chicago Priztker School of Medicine graduating in 2014. During medical school I completed a one year research fellowship as part of the Howard Hughes Medical Fellows program during which I investigated adverse cardiac remodeling as a precursor to heart failure. I came to the University of Wisconsin in 2014 to begin my general surgery residency. I joined Dr. Chesler’s group due to their use of novel in vivo biomechanic techniques to study the relationship between the right ventricle and pulmonary vascular in the setting of disease as well as their multidisciplinary approach which combines engineering, biochemical and clinical expertise. I’m currently developing a model of secondary pulmonary hypertension due to left heart failure in order to allow for characterization of this disease process and identification of novel therapeutic targets. In addition, I’m studying the role of HIF-1α in regulation of pulmonary artery adventitial fibroblasts.
Christopher Zimmerman, MD
I am a general surgery resident taking two years away from clinical work for dedicated research time through WiSOR. I will be working primarily with Dr. Margaret “Gretchen” Schwarze, focusing on perioperative decision making in our elders.
I attended the University of Houston in Houston, Texas, where I obtained a degree in Health. During my undergraduate years I volunteered and ultimately worked for a local hospice and palliative care organization, prompting my interest in medicine. This was followed by medical school at the University of Texas Medical Branch in Galveston, TX, where I first became interested in health sciences research, studying outcomes in minimally invasive breast biopsy. I also developed an interest in surgery during those years, which led me to Madison in 2015 to start my general surgery residency. My current interests involve improving preoperative conversations between surgeons and patients before undergoing high-risk surgery as a way to improve patient and family outcomes, improve quality of life at the end of life, and reduce unnecessary surgery. Current projects include a multi-institution trial using a question prompt list with patients before their initial meeting with their surgeon to improve outcomes, using a novel decision tool called Best-Case/Worst-Case with trauma patients and patients facing an imminent need for dialysis, a survey project analyzing factors which contribute to surgeons performing unnecessary surgery, and developing a standardized training program for the Best-Case/Worst-Case tool. I will be gathering experience in qualitative and quantitative research methods through these projects with Dr. Schwarze and our collaborators in WiSOR. These experiences will also be supported by obtaining a certificate in the Fundamentals of Clinical Research through the UW Institute for Clinical and Translational Research.